Delivering complete aseptic vial handling solutions

14 Aug 2019

Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.

SP Scientific has signed a new partnership agreement with Lab-i-DOSiTECNO Pharma Technologies enabling both companies to offer complete aseptic vial and syringe fill-finish lines lines for injectable, ophthalmic and oral products in liquid and powder form.

Delivering complete aseptic vial handling solutions

This new global partnership brings together best-in-class freeze drying and vial washing/sterilizing technologies from SP Scientific with the advanced and comprehensive vial and syringe filling capabilities of Lab-i-DOSiTECNO.

Oriol Casòliva, CEO of Lab-i-DOSiTECNO commented: “The geographic synergies of SP Scientific and Lab-iDosiTECNO working together will enable us to provide outstanding local support throughout North America and Europe, significantly broadening the reach of both partners.”

Brian Larkin, CEO of SP Scientific added: “In addition, for those who prefer to work with a single supplier for full lines, this new partnership enables us to provide and support these customers with top quality, highly productive aseptic fill-finish line solutions."

Biopharmaceutical products are often frozen and then thawed, freeze-dried to be rehydrated when needed, or encapsulated in liquid form without being touched by the atmosphere. The container that holds the medicine during transportation through a variety of global climates, and how it is filled, is therefore critical to product integrity. SP Scientific, in partnership with Lab-i-DOSiTECNO, now leads the way in the development and manufacture of complete aseptic vial fill-finish lines offering the broadest lyophilization range available today covering cycle development, stability, pilot and clinical batch production, through to full aseptic manufacturing and commercial production batches.

Read More

Related news

HALIX starts operational production with new cGMP facility in Q4-2019

HALIX starts operational production with new cGMP facility in Q4-2019

15 Aug 2019

The five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors and a separate protein manufacturing area with a capacity up to 1,000-L single-use bioreactors.

Read more 
Hikma expands nasal spray capabilities

Hikma expands nasal spray capabilities

12 Aug 2019

Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.

Read more 
How real-world data can revolutionise drug development

How real-world data can revolutionise drug development

9 Aug 2019

Utilising the current data environment and its data pools for the benefit of advancing research.

Read more 
Sartorius launches new services for mammalian cell bank manufacturing

Sartorius launches new services for mammalian cell bank manufacturing

8 Aug 2019

Integrated package of new and established services saves time and minimizes risks.

Read more 
Using mobile phones to fight Alzheimer’s disease

Using mobile phones to fight Alzheimer’s disease

8 Aug 2019

Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy.

Read more 
Cambrex to be acquired by the Permira funds

Cambrex to be acquired by the Permira funds

7 Aug 2019

The CDMO's shareholders will receive $60.00 per share in cash.

Read more 
Automation-compatible prepared culture media plate technology

Automation-compatible prepared culture media plate technology

6 Aug 2019

Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.

Read more 
Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

6 Aug 2019

The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.

Read more 
Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

5 Aug 2019

Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.

Read more 
Croda commits to Science Based Targets for reduction of greenhouse gas emissions

Croda commits to Science Based Targets for reduction of greenhouse gas emissions

5 Aug 2019

Group aiming to achieve a 50% reduction in absolute GHG emissions based on 2006 levels by 2030 and an 80% reduction by 2050.

Read more